Rafferty Asset Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.71M | Sell |
122,262
-6,873
| -5% | -$96.2K | 0.01% | 638 |
|
|
2025
Q1 | $1.76M | Sell |
129,135
-12,175
| -9% | -$166K | 0.01% | 609 |
|
|
2024
Q4 | $2.88M | Buy |
141,310
+23,629
| +20% | +$482K | 0.01% | 541 |
|
|
2024
Q3 | $3.43M | Sell |
117,681
-33,801
| -22% | -$985K | 0.01% | 496 |
|
|
2024
Q2 | $3.52M | Sell |
151,482
-283,427
| -65% | -$6.58M | 0.01% | 492 |
|
|
2024
Q1 | $8.92M | Buy |
434,909
+112,936
| +35% | +$2.32M | 0.03% | 306 |
|
|
2023
Q4 | $6.91M | Buy |
321,973
+92,660
| +40% | +$1.99M | 0.03% | 374 |
|
|
2023
Q3 | $4.73M | Sell |
229,313
-19,213
| -8% | -$396K | 0.03% | 396 |
|
|
2023
Q2 | $7.33M | Sell |
248,526
-8,447
| -3% | -$249K | 0.04% | 323 |
|
|
2023
Q1 | $5.92M | Sell |
256,973
-26,769
| -9% | -$617K | 0.04% | 346 |
|
|
2022
Q4 | $7.89M | Buy |
283,742
+76,374
| +37% | +$2.12M | 0.07% | 267 |
|
|
2022
Q3 | $6.36M | Buy |
207,368
+105,897
| +104% | +$3.25M | 0.07% | 266 |
|
|
2022
Q2 | $2.99M | Sell |
101,471
-74,491
| -42% | -$2.19M | 0.03% | 392 |
|
|
2022
Q1 | $5.66M | Buy |
175,962
+54,207
| +45% | +$1.74M | 0.03% | 354 |
|
|
2021
Q4 | $5.43M | Buy |
121,755
+61,394
| +102% | +$2.74M | 0.03% | 359 |
|
|
2021
Q3 | $3.05M | Buy |
60,361
+25,581
| +74% | +$1.29M | 0.02% | 471 |
|
|
2021
Q2 | $2.73M | Sell |
34,780
-16,725
| -32% | -$1.31M | 0.02% | 538 |
|
|
2021
Q1 | $2.94M | Buy |
51,505
+39,855
| +342% | +$2.28M | 0.02% | 508 |
|
|
2020
Q4 | $976K | Sell |
11,650
-27,468
| -70% | -$2.3M | 0.01% | 501 |
|
|
2020
Q3 | $1.4M | Buy |
39,118
+22,118
| +130% | +$793K | 0.02% | 516 |
|
|
2020
Q2 | $411K | Buy |
+17,000
| New | +$411K | 0.01% | 756 |
|
|
2020
Q1 | – | Sell |
-28,690
| Closed | -$500K | – | 655 |
|
|
2019
Q4 | $500K | Sell |
28,690
-27,690
| -49% | -$483K | 0.01% | 689 |
|
|
2019
Q3 | $864K | Sell |
56,380
-22,541
| -29% | -$345K | 0.01% | 570 |
|
|
2019
Q2 | $1.64M | Buy |
78,921
+28,178
| +56% | +$585K | 0.03% | 464 |
|
|
2019
Q1 | $1.18M | Buy |
+50,743
| New | +$1.18M | 0.02% | 519 |
|